Role of epoetin alfa in maintaining ribavirin dose
- 31 March 2004
- journal article
- review article
- Published by Elsevier in Gastroenterology Clinics of North America
- Vol. 33 (1) , 25-35
- https://doi.org/10.1016/j.gtc.2003.12.002
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Side effects of therapy of hepatitis C and their managementHepatology, 2002
- Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis CHepatology, 2002
- Adherence to combination therapy enhances sustained response in genotype-1–infected patients with chronic hepatitis CGastroenterology, 2002
- Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus InfectionNew England Journal of Medicine, 2002
- Rapid suppression of hematopoiesis by standard or pegylated interferon-αGastroenterology, 2002
- Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trialPublished by Elsevier ,2001
- Use of granulocyte macrophage colony stimulating factor alone or in combination with interferon-alpha-2b for treatment of chronic hepatitis CJournal of Hepatology, 1998
- Case Report: Agranulocytosis induced by interferon-α therapy for chronic hepatitis CJournal of Gastroenterology and Hepatology, 1996
- Effect of recombinant interferons alpha and gamma on human bone marrow- derived megakaryocytic progenitor cellsBlood, 1987
- Changes in the bone marrow of cancer patients treated with recombinant interferon alpha-2The American Journal of Medicine, 1984